We are working on upgrading our websites and despite our best endeavours have experienced census type calamities for almost a week now. Our apologies, we hope to have all problems resolved by Monday August 15th.

deListed Australia



Browse Australian delisted companies0-9A BC DE F GH IJ KL MN OP QR ST UV WX YZ
Browse terminated Australian managed funds0-9A BC DE FGH IJ KL MN OP QR ST UV WX YZ


Find any Australian or New Zealand company or fund (dead or alive) by using SEARCH above or go directly to the site:


Former Name ASX


Former (or subsequent) names

AVASTRA LTD12/12/2007

Shareholder links


Computershare, Level 3, 60 Carrington Street, Sydney NSW 2000
Tel : +61 2 8234 5000
Fax : +61 2 8235 8150
RegistryWebsite RegistryEmail

Company details

Address: Riverside Life Sciences Centre , 11 Julius Avenue , NORTH RYDE , NSW, AUSTRALIA, 2113
Tel:  (02) 8873 6000 Fax: (02) 8873 6050

Date first listed: 24/06/2004
Company Secretary: Ms Eva Liu, BBus
Sector: Pharmaceuticals & Biotechnology Industry Group: XHJ
Activities: Wound repair company using protein based technology but is seeking to change activities and acquire interests in the sleep diagnostic services area
name changed to Avastra Sleep Centres Limited12/12/2007
shares reinstated to quotation06/12/2006
announces the purchase of Pacific Sleep Medicine (PSM) - a profitable and long-established, California-based, sleep centre business - the purchase arrangements entered into by Avastra comprise cash payments spread over the next 4 years, with the last three installments variable depending on the business's performance over that period - the initial payment is $US2.0 million - as part of the deal, Avastra will immediately issue PSM shareholders 5 million Avastra shares30/11/2006
releases its AGM Investor Presentation and announces the results of today's AGM held in Melbourne (all resolutions passed on a show of hands)22/11/2006
releases a Supplementary Prospectus lodged with ASIC today16/11/2006
Avastra anticipates being in a position to provide detailed information in the near future regarding the execution of another binding Purchase Agreement with one of the sleep centre operations previously announced to the market and described in the Prospectus dated 5 October 2006 - in order to give shareholders an opportunity to consider whether to exercise their entitlements with the benefit of this new information, the Company announces that it has extended the closing date for the non-renounceable Entitlements Offer to 24 November 200610/11/2006
cash flow for the quarter ended 30 September 2006 reflects a deficit at operating level of $479k27/10/2006
releases annual report and gives Notice that the sixth Annual General Meeting will be held at 10:30am on Wednesday 22 November 2006 at Morgans @ 401, Mezzanine Level, 401 Collins Street, Melbourne VIC 300024/10/2006
company issues a supplementary prospectus - shareholders are invited "to consider the contents of the Prospectus upon receipt"20/10/2006
company lodges a prospectus today for an entitlements offer, under which it is offering shareholders the opportunity to subscribe for 1 new share for every 2 held as at the record date at a price of 20c (further details are in the prospectus which is available on Avastra's website www.avastra.com)05/10/2006
company releases its annual report27/09/2006
company today signs a non-binding Letter of Intent (LOI) to purchase a company with ten sleep centres in the United States - the LOI provides Avastra with an exclusive period for finalising a Purchase Agreement with the seller until November 30, 200620/09/2006
releases preliminary final report13/09/2006
Avastra's new contact numbers effective as of today: Tel: (02) 9888 7184 Fax: (02) 9889 4895 - address remains the same: Riverside Life Sciences Centre 11 Julius Avenue North Ryde NSW 211305/09/2006
shares suspended from quotation29/08/2006
shares reinstated to quotation05/07/2006
shares suspended from quotation04/07/2006

ASX Announcements (courtesy of ASX)


Your comments

Please read our Terms before viewing comments.


Company Updates

Post your comments here

Please read our Terms before posting comments.
    You can post a comment here about this company

    Please click in the "I'm not a robot" box. If an image appears, enter the word/figures you see in the image.

    Posting your comments. Please wait...

    Directors' on-market share transactions (last 5)


    Click here for the last 20 transactions all companies

    Directors & Executives (current)

    Gregory FaganChairman
    Matt HarrisCEO
    Guy AirdNon Exec Director
    Michael DalsinDirector
    Hugh DockerDirector
    Roger GreeneDirector
    George SteinfelsDirector

    Date of first appointment, title may have changed.

    Directors & Executives (former)


    Date of first appointment, title may have changed.